Stefan Bergt1, Matthias Gruenewald, Claudia Beltschany, Andrea Grub, Tobias Neumann, Martin Albrecht, Brigitte Vollmar, Kai Zacharowski, Jan P Roesner, Patrick Meybohm. 1. 1Department of Anesthesiology and Critical Care Medicine, University Hospital Rostock, Rostock, Germany.2Department of Anesthesiology and Intensive Care Medicine, Schleswig-Holstein University Hospital, Campus Kiel, Kiel, Germany.3Department of Anesthesiology and Intensive Care Medicine, University Hospital of Cologne, North Rhine-Westphalia, Germany.4Institute for Experimental Surgery, Rostock University, Rostock, Germany.5Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt am Main, Germany.6Department of Anesthesiology and Intensive Care Medicine, Suedstadt Hospital, Rostock, Germany.
Abstract
OBJECTIVES: The fibrin-derived peptide Bβ15-42 (FX06) has been proven to attenuate ischemia/reperfusion injury. We tested the hypothesis that Bβ15-42 improves survival rate and neurocognitive recovery after cardiopulmonary resuscitation. DESIGN: Pig and mouse model of cardiopulmonary resuscitation. SETTING: Two university hospitals. SUBJECTS: Pigs and mice. INTERVENTIONS: Pigs (n = 16) were subjected to 8-minute cardiac arrest. Successful resuscitated pigs (n = 12) were randomized either to 3 mg/kg Bβ15-42 followed by a continuous infusion of 1 mg/kg/hr for 5 hours (pFX06; n = 6) or the control group (pCONTROL; n = 6). Cardiac damage, function, and hemodynamics were recorded up to 8 hours. Mice (n = 52) were subjected to 4-minute cardiac arrest followed by cardiopulmonary resuscitation, and randomized either to two boli of 2.4 mg/kg Bβ15-42 (mFX06; n = 26) or the control group (mCONTROL; n = 26). Fourteen-day survival rate, neurocognitive function, and endothelial integrity (additional experiment with n = 26 mice) were evaluated. MEASUREMENTS AND MAIN RESULTS: Bβ15-42 reduced cumulative fluid intake (3,500 [2,600-4,200] vs 6,800 [5,700-7,400] mL; p = 0.004) within 8 hours in pigs. In mice, Bβ15-42 improved 14-day survival rate (mFX06 vs mCONTROL; 11/26 vs 6/26; p < 0.05) and fastened neurocognitive recovery in the Water-Maze test (15/26 vs 9/26 mice with competence to perform test; p < 0.05). Bβ15-42-treated mice showed a significant higher length of intact pulmonary endothelium and reduced pulmonary leukocyte infiltration. CONCLUSIONS: This study confirms the new concept of an important role of fibrin derivatives in global ischemia/reperfusion injury, which can be attenuated by the fibrin-derived peptide Bβ15-42.
OBJECTIVES: The fibrin-derived peptide Bβ15-42 (FX06) has been proven to attenuate ischemia/reperfusion injury. We tested the hypothesis that Bβ15-42 improves survival rate and neurocognitive recovery after cardiopulmonary resuscitation. DESIGN:Pig and mouse model of cardiopulmonary resuscitation. SETTING: Two university hospitals. SUBJECTS:Pigs and mice. INTERVENTIONS:Pigs (n = 16) were subjected to 8-minute cardiac arrest. Successful resuscitated pigs (n = 12) were randomized either to 3 mg/kg Bβ15-42 followed by a continuous infusion of 1 mg/kg/hr for 5 hours (pFX06; n = 6) or the control group (pCONTROL; n = 6). Cardiac damage, function, and hemodynamics were recorded up to 8 hours. Mice (n = 52) were subjected to 4-minute cardiac arrest followed by cardiopulmonary resuscitation, and randomized either to two boli of 2.4 mg/kg Bβ15-42 (mFX06; n = 26) or the control group (mCONTROL; n = 26). Fourteen-day survival rate, neurocognitive function, and endothelial integrity (additional experiment with n = 26 mice) were evaluated. MEASUREMENTS AND MAIN RESULTS: Bβ15-42 reduced cumulative fluid intake (3,500 [2,600-4,200] vs 6,800 [5,700-7,400] mL; p = 0.004) within 8 hours in pigs. In mice, Bβ15-42 improved 14-day survival rate (mFX06 vs mCONTROL; 11/26 vs 6/26; p < 0.05) and fastened neurocognitive recovery in the Water-Maze test (15/26 vs 9/26 mice with competence to perform test; p < 0.05). Bβ15-42-treated mice showed a significant higher length of intact pulmonary endothelium and reduced pulmonary leukocyte infiltration. CONCLUSIONS: This study confirms the new concept of an important role of fibrin derivatives in global ischemia/reperfusion injury, which can be attenuated by the fibrin-derived peptide Bβ15-42.
Authors: Ye Ma; Chan Chen; Shu Zhang; Qiao Wang; Hai Chen; Yuanlin Dong; Zheng Zhang; Yan Li; Zhendong Niu; Tao Zhu; Hai Yu; Bin Liu Journal: Oncotarget Date: 2017-05-23
Authors: Jan Kloka; Benjamin Friedrichson; Stephanie Dauth; Ann Christina Foldenauer; Anita Bulczak-Schadendorf; Maria J G T Vehreschild; Francisco Maio Matos; Antoni Riera-Mestre; Antoinette D I van Asselt; Edoardo De Robertis; Vilma Traskaite Juskeviciene; Patrick Meybohm; Dana Tomescu; Karine Lacombe; Coen D A Stehouwer; Kai Zacharowski Journal: Trials Date: 2022-08-19 Impact factor: 2.728
Authors: Chan Chen; Changliang Liu; Zhendong Niu; Ming Li; Yuhan Zhang; Rui Gao; Hai Chen; Qiao Wang; Shu Zhang; Ronghua Zhou; Lu Gan; Zheng Zhang; Tao Zhu; Hai Yu; Jin Liu Journal: Aging (Albany NY) Date: 2020-07-21 Impact factor: 5.682
Authors: Tobias Neumann; Simon-Richard Finke; Maja Henninger; Sebastian Lemke; Ben Hoepfner; Daniel Steven; Alexandra C Maul; Daniel C Schroeder; Thorsten Annecke Journal: Resusc Plus Date: 2020-06-01